Economic and clinical impact of innovative pharmacy benefit designs in the management of diabetes pharmacotherapy
Well review the issue and work on a solution
Abbreviations A: Amyloid AD: Alzheimers disease BBB: Bloodbrain barrier CSF: Cerebrospinal fluid CV: Cardiovascular FDA: US Food and Drug Administration GLP-1: Glucagon-like peptide-1 GLP-1RA: Glucagon-like peptide-1 receptor agonist hs-CRP: High-sensitivity C-reactive protein MACE: Major adverse cardiovascular event MCI: Mild cognitive impairment OD: Once daily OW: Once weekly p-tau: Phosphorylated tau s.c.: subcutaneous T2D: Type 2 diabetes References Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chtelat G, Teunissen CE, et al
[] Herrmann et al
If your pen sits on the counter for 4 hours each week during use, those hours add up
On February 6, the Department of Health and Human Services (HHS) General Counsel Mike Stuart announced via X that he would refer the compounded drug to the Department of Justice (DOJ) for potential violations of the Hims & Hers swiftly responded on X, stating that after conversations with industry stakeholders, theyd decided to stop offering the compounded semaglutide pill